Lack of association between loneliness, social isolation and inflammation in people living with HIV aged ≥50 years: Results from the sub-study “No One Alone-Gesida Study”
José Ramón Blanco, Isabel Sanjoaquín(Hospital Clínico Universitario Lozano Blesa), Antonio Ocampo(University Hospital Complex Of Vigo), María Saumoy(Bellvitge University Hospital), Joanna Cano-Smith(Hospital Universitario La Paz), Helena Albendín-Iglesias(Instituto Murciano de Investigación Biosanitaria), Lourdes Romero(Center for Biomedical Research of La Rioja), Magdalena Muelas‐Fernandez(Hospital de Viladecans), Inmaculada González‐Cuello(Hospital Vega Baja), Alicia González-Baeza(Universidad Autónoma de Madrid), Cristina Tomás‐Jiménez(Hospital Reina Sofía de Murcia), Ana Barrios-Blandino(Instituto de Salud Carlos III), Herminia Esteban(Fundación Seimc-Gesida), Inmaculada Jarrín(Instituto de Salud Carlos III), Jésica Abadía‐Otero(Seattle Children's Hospital), Noemí Cabello‐Clotet(Hospital Clínico San Carlos), Javier de la Torre, Jordi Puig(Universitat Autònoma de Barcelona), Julián Olalla(Hospital Costa del Sol), María José Galindo Puerto(Hospital Clínico Universitario de Valencia), Carmen Hidalgo‐Tenorio(Hospital Universitario Virgen de las Nieves), Rafael Torres(Universidade Federal de Minas Gerais), Laura Pérez‐Martínez(Hospital San Pedro), M. Montero(Universitat de València), Dolores Merino-Muñoz(Hospital Juan Ramón Jiménez), Lucio García‐Fraile(Instituto de Salud Carlos III), Verónica Pérez‐Esquerdo(Instituto de investigación sanitaria y biomédica de Alicante), Maria Angeles Fernandes-López(Hospital Universitario Virgen de la Arrixaca), A. López-Lirola, Eugenia Negredo-Puigmal(Hospital Universitari Germans Trias i Pujol)
Cited by 0
Related Papers
Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
|The Lancet HIV|2023|506
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy
|Annals of Internal Medicine|2020|342
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
|Clinical Microbiology and Infection|2020|128
Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma
|Haematologica|2007|123
Effect Estimates in Randomized Trials and Observational Studies: Comparing Apples With Apples
|American Journal of Epidemiology|2019|116